U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. BOOSTRIX
  1. Vaccines

BOOSTRIX

STN: BL 125106
Proper Name: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed
Tradename: BOOSTRIX
Manufacturer: GlaxoSmithKline Biologicals
Indication: 

BOOSTRIX is a vaccine indicated for:

  • active booster immunization against tetanus, diphtheria, and pertussis in individuals aged 10 years and older
  • immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age.

Product Information

Supporting Documents

Back to Top